Australia's 4DMedical extends climb as CT:VQ scans secure US reimbursement
** Shares of 4DMedical 4DX.AX rise as much as 26.4% to A$1.46, their highest level since November 23, 2021 ** 4DMedical stock extends gains to a second straight day after co said its CT:VQ scans becomes eligible for U.S. Medicare reimbursements ** Stock top gainer in the ASX All Ordinaries Index .AORD ** About 13.4 million shares change hand, 2.9 times their 30-day average ** Stock up 185% this year, including the day's move (Reporting by John Biju in Bengaluru) ((John.Biju@thomsonreuters.com;))
Recent news on 4DMedical
See all newsBrief: 4Dmedical Receives TGA Approval For CTVQ In Australia
Brief: 4Dmedical Launches Clear Clinical Evidence Program
Brief: 4Dmedical Creates EU Platform Via Contextflow Acquisition
Australia's 4DMedical rises on establishing European platform via acquisition
Brief: 4Dmedical Says CT:VQ Enters US Outpatient Market Via Simonmed's 170-Site Network